Brought to you by Northeast Alabama Regional Medical Center
Tue, 14 Feb 2012 09:00:00 EST (New York, NY, February 14, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the serious side effects of the drug Fosamax, is cautiously optimistic about the possibility that a new treatment might improve bone growth.
According to a press release from the University of California, '[a] research team led by UC Davis Health System scientists has developed a novel technique to enhance bone growth by using a molecule which, when injected into the bloodstream, directs the body's stem cells to travel to the surface of bones.' The results of the study were published in Nature Medicine.
Wei Yao, the chief investigator and lead author of the study, commented that while there are many stem cells, even in the elderly, those stem cells 'do not readily migrate to bone.' Discovering a molecule that attaches to stem cells and guides them to desired targets 'is a real breakthrough.'
'Osteoporosis is a major public health problem for 44 million Americans,' the release states. 'One in two women will suffer a fracture due to osteoporosis in their lifetime. Although effective medications are available to help prevent fracture risk, including alendronate, their use is limited by potential harmful effects of long-term use.'
Despite being the most popular osteoporosis treatment on the market, Fosamax has been linked to several serious side effects. In 2004, researchers found a causal connection between Fosamax and osteonecrosis of the jaw, a condition that causes the jawbone to literally die because of a lack of blood supply. More recently, there has been a link between Fosamax and low-impact femur fractures experienced from standing height or less. Evidence is mounting that Fosamax and similar drugs prescribed to treat osteoporosis cause a dramatic increase in the risk of this kind of rare fracture to the thigh bone.
The Rottenstein Law Group advises anyone with a friend or family member who has been prescribed Fosamax or another osteoporosis drug to recommend to that person that he or she consult a physician immediately, then speak to a qualified Fosamax lawyer. The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations. Affected individuals are advised to keep apprised of the latest news concerning the Fosamax femur fracture lawsuits by checking the Fosamax Femur Fracture Lawsuit Information Center for updated information. The site is equipped with easy-to-use social media features which will enable users to spread the word about the dangers of Fosamax.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.
(New York, NY, February 14, 2012) The Rottenstein Law Group, which represents clients with claims stemming from the serious side effects of the drug Fosamax, is cautiously optimistic about the possibility that a new treatment might improve bone growth.